Business Context and Reporting Period
Company: Village Farms International, Inc. (VFF)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: VFF operates five segments: Produce (VF Fresh), Canadian Cannabis (Pure Sunfarms and Rose LifeScience), U.S. Cannabis (Balanced Health), Clean Energy (VFCE), and Leli (Netherlands cannabis). The company is a pioneer in Controlled Environment Agriculture (CEA) and has expanded into legal cannabis markets in Canada, the U.S. (CBD), and the Netherlands.
Key Financial Metrics (Year Ended Dec 31, 2024)
| Metric | 2024 Value (USD) | 2023 Value (USD) |
|---|---|---|
| Sales | $336.2 million | $285.6 million |
| Gross Profit | $47.4 million | $49.4 million |
| Gross Margin | 14.1% | 17.3% |
| Net Loss (GAAP) | $(35.9) million | $(34.8) million |
| Adjusted EBITDA | $1.8 million | $7.6 million |
| Cash and Equivalents | $24.6 million | $35.3 million |
| Working Capital | $53.8 million | $79.6 million |
| Total Debt (Outstanding) | $44.6 million | $52.1 million |
Note: Debt figures include current maturities and long-term debt. Adjusted EBITDA is a non-GAAP measure.
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 18% to $336.2 million, driven by a 31% increase in Canadian Cannabis sales and a 12% increase in Produce sales. U.S. Cannabis sales declined 14% due to regulatory restrictions on CBD in eight states and market competition.
- Profitability Decline: Net loss widened slightly to $35.9 million. Adjusted EBITDA dropped 76% to $1.8 million, primarily due to a $10.4 million non-cash inventory impairment in the Canadian Cannabis segment and a $11.9 million goodwill/intangible impairment in the U.S. Cannabis segment.
- Segment Performance:
- Canadian Cannabis: Sales grew significantly, but gross margin fell to 21% (from 32%) due to the inventory write-down. The segment remains the largest revenue contributor.
- Produce: Improved gross margin to 3% (from 0%) due to operational efficiencies and lower cost per pound, though tomato prices decreased slightly.
- U.S. Cannabis: Continued to underperform with a net loss of $13.3 million, leading to full impairment of goodwill and brand intangibles.
- Leli (Netherlands): Acquired 100% ownership in Q4 2024; began sales to Dutch coffee shops in Q1 2025.
- Debt Covenants: The company was not in compliance with fixed charge coverage ratio covenants under its FCC Term Loan and Pure Sunfarms Term Loans as of year-end but obtained waivers from lenders.
Guidance, Outlook, Risks, and Unusual Items
- Internal Controls: The company identified material weaknesses in internal controls over financial reporting related to IT general controls (user access and program change management) and journal entry reviews in the Produce segment. KPMG issued an adverse opinion on the effectiveness of internal controls. Remediation is ongoing for 2025.
- Nasdaq Compliance: VFF received notice of non-compliance with the Nasdaq minimum bid price requirement (stock closed below $1.00 for 30 consecutive days). The company has until April 16, 2025, to regain compliance or face potential delisting.
- Regulatory Risks:
- U.S. Rescheduling: The company is actively participating in the DEA administrative law judge hearing regarding the rescheduling of marijuana from Schedule I to Schedule III. Proceedings are currently stayed pending an interlocutory appeal.
- CBD Restrictions: New state-level restrictions on hemp-derived CBD products continue to challenge the U.S. Cannabis segment.
- Strategic Moves: The company is exploring a "transformative change" in its produce business, including an ongoing sale process for its Monahans, Texas greenhouse facility.
- Unusual Items:
- Inventory Impairment: $10.4 million write-down in Canadian Cannabis for older manufactured products where rework costs exceeded resell value.
- Goodwill Impairment: $11.9 million charge in U.S. Cannabis due to underperformance and regulatory headwinds.
Investor Verification Checklist
- Internal Control Remediation: Verify the timeline and progress of remediation plans for the identified material weaknesses in IT and journal entry controls.
- Nasdaq Listing Status: Monitor the stock price to ensure it meets the $1.00 minimum bid requirement before the April 16, 2025 deadline to avoid delisting.
- Debt Covenant Compliance: Confirm that the company regains compliance with its fixed charge coverage ratio covenants in the next testing period (Q1 2025 for Pure Sunfarms, Year-end 2025 for FCC).
- U.S. Cannabis Viability: Assess the impact of ongoing state-level CBD restrictions and the potential for further goodwill impairments in the U.S. segment.
- Produce Asset Sales: Track the status of the sale process for the Monahans greenhouse facility and other potential asset divestitures.
- Leli Ramp-Up: Monitor the revenue contribution from the Leli Netherlands segment as it ramps up production and sales in 2025.